Skip to content

Medical emergency? What to do

Withdrawn drug may help in Crohn's disease

3-RXPublished November 8, 20051 min read

Key points

  • A drug pulled from the market by the manufacturer following reports of serious side effects in patients with multiple sclerosis may help some sufferers of Crohn's disease, a new study showed.
  • Crohn's disease is an inflammation of the digestive tract that affects a half million Americans, many age 15 to 35.
  • But when people who seemed to respond to the initial treatment with the drug were kept on the medicine for another 46 weeks, 61 percent responded versus 28 percent who got the placebo, the study said.
  • In an editorial, Daniel Podolsky of Massachusetts General Hospital said that "our understanding of the benefits of natalizumab in patients with Crohn's disease is too incomplete" to say whether its potential benefits are worth the risk.

A drug pulled from the market by the manufacturer following reports of serious side effects in patients with multiple sclerosis may help some sufferers of Crohn's disease, a new study showed.

But in many instances, the drug natalizumab will be no better than a placebo, said the study published in the November 3rd edition of The New England Journal of Medicine.

Crohn's disease is an inflammation of the digestive tract that affects a half million Americans, many age 15 to 35.

In a 10-week test of more than 900 volunteers with Crohn's disease, the response rate among placebo recipients was 49 percent and the rate for natalizumab users was lackluster -- just 7 percentage points higher.

But when people who seemed to respond to the initial treatment with the drug were kept on the medicine for another 46 weeks, 61 percent responded versus 28 percent who got the placebo, the study said.

The drug is sold under the brand name Tysabri by Irish drug maker Elan Corp. and Biogen Idec Inc. of Cambridge, Massachusetts.

In an editorial, Daniel Podolsky of Massachusetts General Hospital said that "our understanding of the benefits of natalizumab in patients with Crohn's disease is too incomplete" to say whether its potential benefits are worth the risk.

The drug was withdrawn in February after a multiple sclerosis patient died from a brain disorder known as progressive multifocal leukoencephalopathy. The companies said last month a new safety study had failed to uncover new cases in patients' treatment for Crohn's or rheumatoid arthritis.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBowel Problems

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.